InsiderTrades

Form 4 for MRNA Moderna

Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001127602-22-008034 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-03 2022-03-02 MRNA Hoge Stephen Pres S - Sale+OE $149.44 -10.0K 1.61M -0.6% -$1.49M
D 2022-03-03 2022-03-02 MRNA Hoge Stephen Pres M - OptEx $0.99 +10.0K 1.62M +0.6% +$9,900
DM 2022-03-03 2022-03-01 MRNA Hoge Stephen Pres A - Grant $0.00 +52.7K 42.3K New $0
D 2022-03-03 2022-03-02 MRNA Hoge Stephen Pres M - OptEx $0.00 -10.0K 107.4K -9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-02 S D 10,000 $149.44 1,610,791 D — —
2 Common Common Stock 2022-03-02 M A 10,000 $0.99 1,620,791 D — —
3 Derivative Restricted Stock Units 2022-03-01 A A 10,425 $0.00 10,425 D $0.00 · — to — 10,425 Common Stock (F4) 25% of the shares subject to this restricted stock unit award will vest on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
4 Derivative Stock Option (Right to Buy) 2022-03-01 A A 42,282 $0.00 42,282 D $149.52 · 2023-03-01 to 2032-03-01 42,282 Common Stock (F3) 25% of this option will vest and become exercisable on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
5 Derivative Stock Option (Right to Buy) 2022-03-02 M D 10,000 $0.00 107,431 D $0.99 · — to 2023-08-19 10,000 Common Stock (F5) This option is fully vested and exercisable.